“AIDS is not a business”: A study in global corporate responsibility – securing access to low-cost HIV medications [Book Review]
David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Journal of Business Ethics 73 (1):65 - 75 (2007)
At the end of the 1990s, Brazil was faced with a potentially explosive HIV/AIDS epidemic. Through an innovative and multifaceted campaign, and despite initial resistance from multinational pharmaceutical companies, the government of Brazil was able to negotiate price reductions for HIV medications and develop local production capacity, thereby averting a public health disaster. Using interview data and document analysis, the authors show that the exercise of corporate social responsibility can be viewed in practice as a dynamic negotiation and an interaction between multiple actors. Action undertaken in terms of voluntary CSR alone may be insufficient. This finding highlights the importance of a strong role for national governments and international organizations to pressure companies to perform better
|Keywords||Brazil compulsory licensing corporate social responsibility developing countries HIV/AIDS multinational pharmaceutical companies patents TRIPS WTO|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
Matthew Lee & Jillian Kohler (2010). Benchmarking and Transparency: Incentives for the Pharmaceutical Industry's Corporate Social Responsibility. [REVIEW] Journal of Business Ethics 95 (4):641-658.
Pallab Paul & Kausiki Mukhopadhyay (2010). Growth Via Intellectual Property Rights Versus Gendered Inequity in Emerging Economies: An Ethical Dilemma for International Business. [REVIEW] Journal of Business Ethics 91 (3):359 - 378.
Gordon Hull (2012). Robert Merges: Justifying Intellectual Property. [REVIEW] Ethics and Information Technology 14 (2):169-177.
Similar books and articles
Loretta M. Kopelman & Anton A. van Niekerk (2002). AIDS and Africa. Journal of Medicine and Philosophy 27 (2):139 – 142.
Douglas K. Peterson (2007). Partner Selection for Corporate Social Responsibility Efforts. International Corporate Responsibility Series 3:173-187.
Paul Kapelus (2002). Mining, Corporate Social Responsibility and the "Community": The Case of Rio Tinto, Richards Bay Minerals and the Mbonambi. [REVIEW] Journal of Business Ethics 39 (3):275 - 296.
David Rygl, Markus G. Kittler & Carina Friedmann (2007). Fighting HIV/AIDS. International Corporate Responsibility Series 3:189-205.
James B. McArthur, As the Tide Turns: The Changing HIV/AIDS Epidemic and the Criminalization of HIV Exposure.
Adedayo O. Adeyemi & M. H. Ayegboyin (2005). The Use of Information and Communication Technologies for Providing Access to HIV/AIDS Information Management in a Resource-Poor Country. International Corporate Responsibility Series 2:393-400.
Klaus M. Leisinger (2005). The Corporate Social Responsibility of The Pharmaceutical Industry. Business Ethics Quarterly 15 (4):577-594.
David Barnard (2002). In the High Court of South Africa, Case No. 4138/98: The Global Politics of Access to Low-Cost AIDS Drugs in Poor Countries. [REVIEW] Kennedy Institute of Ethics Journal 12 (2):159-174.
Conceição Soares (2007). The HIV/AIDS Crisis and Corporate Moral Responsibility in the Light of the Levinasian Notions of Proximity and the Third. Business Ethics 16 (3):278–285.
William Flanagan & Gail Whiteman (2005). “AIDS is Not a Business”. International Corporate Responsibility Series 2:375-391.
Added to index2009-01-28
Total downloads22 ( #121,093 of 1,700,235 )
Recent downloads (6 months)9 ( #69,042 of 1,700,235 )
How can I increase my downloads?